Delivery Order SPE2DB24D2208-SPE2DB25FHJDF
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,017.78 by the Defense Logistics Agency on July 18, 2025, with an ultimate completion date of July 21, 2025. The delivery order, issued under a firm fixed-price contract type with no set-aside designation, covers the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used in treating chronic obstructive pulmonary...
- The Defense Logistics Agency awarded a delivery order valued at $3,046.46 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (a combination respiratory medication), with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office in...
- AmerisourceBergen Drug Corp received a delivery order valued at $1,513.12 from the Defense Logistics Agency (DLA) on August 7, 2025, for Trelegy Ellipta 200-62.5-25, a combination respiratory medication used in treating chronic obstructive pulmonary disease. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. This delivery order is performed at the company's corporate office location...
- AmerisourceBergen Drug Corp received a delivery order contract valued at $37,479.45 from the Defense Logistics Agency's Medical Supply Chain on August 21, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, reflecting the company's established capability to meet federal pharmaceutical procurement requirements. The contract was completed on August 22, 2025, with performance...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,355.98 Firm Fixed Price Delivery Order is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of July 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $34,679.80 firm fixed-price delivery order is for TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
- The Defense Logistics Agency awarded a delivery order valued at $2,658.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory maintenance medication supplied in a 60-dose inhaler configuration. Awarded on July 21, 2025, with completion targeted for July 22, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for pharmaceutical supplies valued at $2,186.63. The order is for Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease, with an ultimate completion date of July 24, 2025. This firm fixed price delivery order represents a non-competitive award utilizing AmerisourceBergen's existing contract vehicle and reflects the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,353.63 firm fixed price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of October 25, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $3,736.05, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The delivery order has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is...
- SPE2DB24D2208Indefinite Delivery Contract
- SPE2DB24D2208-SPE2DB25FHJDFDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $23,940.27 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 27, 2025, with an ultimate completion date of August 28, 2025. The delivery order, issued without set-aside designation through competitive procedures, covers TRELEGY ELLIPTA 200-62.5-25 (a combination inhalation medication for chronic obstructive pulmonary disease) in a 60-unit package. This award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The DLA's Medical Supply Chain utilizes this comprehensive IDC to procure a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates its established capability to fulfill federal medical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. The DLA Troop Support is planning the Pharmaceutical Prime Vendor Global Program Generation V contracts, anticipated to involve multiple awards across separate regions, reflecting the agency's commitment to maintaining a diversified, competitive supplier base for critical pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.9k | 8/27/25 |